Keebeck Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Keebeck Wealth Management, LLC

$667 Million
Q3 2024

A detailed history of Keebeck Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Keebeck Wealth Management, LLC holds 21,283 shares of BMY stock, worth $1.23 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

21,283

Previous 21,277 0.03%

Holding current value

$1.23 Million

Previous $883,000 24.69%

% of portfolio

0.16%

Previous 0.13%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $237 - $310	6 Added 0.03%	21,283 $1.1 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $399,602 - $526,084	9,928 Added 87.48%	21,277 $883,000
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $41,022 - $46,512	-855 Reduced 7.01%	11,349 $615,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $220,438 - $263,043	-4,547 Reduced 27.14%	12,204 $626,000
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $372,695 - $416,731	6,438 Added 62.43%	16,751 $972,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $322,372 - $357,944	5,060 Added 96.33%	10,313 $659,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $100,142 - $113,583	1,524 Added 40.87%	5,253 $364,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $5,546 - $6,568	81 Added 2.22%	3,729 $268,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $25 - $14,906	-194 Reduced 5.05%	3,648 $259,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.33 Million - $1.55 Million	-24,717 Reduced 86.55%	3,842 $240,000
Q3 2021 Nov 16, 2021	SELL	$59.17 - $69.31 $52,247 - $61,200	-883 Reduced 3.0%	28,559 $1.7 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $1.55 Million - $1.69 Million	25,000 Added 562.81%	29,442 $1.97 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $442,320 - $497,479	-7,454 Reduced 62.66%	4,442 $283,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $259,137 - $293,649	4,488 Added 60.58%	11,896 $744,000
Q3 2020 Nov 02, 2020	SELL	$57.43 - $63.64 $51,572 - $57,148	-898 Reduced 10.81%	7,408 $446,000
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $455,334 - $532,331	8,306 New	8,306 $488,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $129,456 - $188,129	-2,790 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $137,295 - $179,090	2,790 New	2,790 $178,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Wealth Management, LLC with notifications on news.

Account

Keebeck Wealth Management, LLC Bristol Myers Squibb CO Transaction History